Can a simple nerve block replace opioids after heart device surgery?
NCT ID NCT05283980
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This trial tests whether a pectoral nerve block using the anesthetic bupivacaine can reduce pain and opioid use in adults receiving a cardiac implantable electronic device (CIED). Participants are randomly assigned to receive either the nerve block or a placebo injection. The study measures opioid consumption and pain scores over the first 24 hours after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a pectoral nerve block using the anesthetic bupivacaine
- What this could lead to
- If it works, this could offer a way to manage pain after cardiac device surgery with fewer opioids.
- What could go wrong
- This is a small pilot study, so results may not apply broadly. The nerve block carries rare risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE, UNSPECIFIED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BIDMC
Boston, Massachusetts, 02130, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Could a gentle yoga practice turn down the Body's pain and inflammation?